There have been several studies on the expression and role of estrogen receptor β in endometrial cancer with conflicting results (reviewed in [63]), but analysis of the TCGA data [8] suggests that ER is expressed at much higher levels (2.9-fold) on average than estrogen receptor β in endometrial tumors. This evidence concerns the gene ESR1 and endometrial cancer.